Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.624
-0.026 (-1.59%)
Jul 10, 2026, 12:00 PM EDT - Market open
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $300.86 million as of July 10, 2026. Its market cap has increased by 149.34% in one year.
Market Cap
300.86M
Enterprise Value
212.02M
1-Year Change
149.34%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $300.86M, a decrease of -88.35%. That is a compound annual growth rate of -53.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 294.60M | -3.15% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 324.74M |
| Lineage Cell Therapeutics | 321.59M |
| Eledon Pharmaceuticals | 319.26M |
| InflaRx | 303.42M |
| SAB Biotherapeutics | 302.80M |
| Bicycle Therapeutics | 291.81M |
| MacroGenics | 290.48M |
| Galectin Therapeutics | 287.79M |